chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Had a Reaction; Not doing well; Rash area Peels, New Skin is Thick and Leathery; Can Hardly Move; Tender Joints; Joint Pain (Left Knee, Left Leg, all Hands Joints); Red Rash on Abdomen, Back , Arm, Chest and Groin Area; This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE REACTION (Had a Reaction), MALAISE (Not doing well), EXFOLIATIVE RASH (Rash area Peels, New Skin is Thick and Leathery), GAIT DISTURBANCE (Can Hardly Move) and TENDERNESS (Tender Joints) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 26-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Mar-2021, the patient experienced ADVERSE REACTION (Had a Reaction), MALAISE (Not doing well), EXFOLIATIVE RASH (Rash area Peels, New Skin is Thick and Leathery), GAIT DISTURBANCE (Can Hardly Move), TENDERNESS (Tender Joints), ARTHRALGIA (Joint Pain (Left Knee, Left Leg, all Hands Joints)) and RASH (Red Rash on Abdomen, Back , Arm, Chest and Groin Area). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL A) ongoing since an unknown date at a dose of 2 UNK, bid and CEFIXIME (FLEXERIL [CEFIXIME]) at a dose of 1 dosage form. At the time of the report, ADVERSE REACTION (Had a Reaction), MALAISE (Not doing well), EXFOLIATIVE RASH (Rash area Peels, New Skin is Thick and Leathery), GAIT DISTURBANCE (Can Hardly Move), TENDERNESS (Tender Joints), ARTHRALGIA (Joint Pain (Left Knee, Left Leg, all Hands Joints)) and RASH (Red Rash on Abdomen, Back , Arm, Chest and Groin Area) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       For mRNA-1273 (COVID 19 Vaccine Moderna)(intramuscular), the reporter did not provide any causality assessment. action taken with mRNA-1273 (COVID 19 Vaccine Moderna)(intramuscular), was unknown  no concomitant medications were reported
Patient received the covid vaccine dose #2  on 1/5/2021.   She tolerated the vaccinations without problem.  She reported that she is very concerned that the second dose of Pfizer vaccine was administer at an "unusual site" in her arm where the adipose tissue.  She took picture of the injection site.  Denies any pain, swelling, redness at the injection site. She is concerned about the efficacy of the second dose.
Pfizer-BioTech COVID-19 Vaccine EUA Shot 1: I had reported bleeding for 1 month. I went to doctor to rule out other reasons. Yes, highly a reaction to shot. Shot 2: THIS REPORT: now I haven't bled at all, plus other extreme symptoms. Like a rapid injection to go into menopause immediately! Side note: a family relative (early 30s) had a miscarriage soon after a shot.  Please ** HALT VACCINES FOR GIRLS IMMEDIATELY ** Especially for UNDER 16; I'd even recommend STOP for under 40 In your emergency roll-out trials, you may have not seen an negative impact regarding fertility specifically (as those are the articles I keep coming across), HOWEVER THERE IS A NEGATIVE IMPACT on girls reproductive system!!  Please ** HALT VACCINES FOR GIRLS IMMEDIATELY ** Please revisit your research and development. Remember shot was approved for emergency and NOT APPROVED. Please protect the girls. Remember, they are the ones that keep the human race going by having babies.  Please ** HALT VACCINES FOR GIRLS IMMEDIATELY **
Patient received Johnson & Johnson vaccine while under the age of 18.  Patient was registered, checked in, & seemed to have received vaccine.
pt recvd vax; fever, muscle aches, ha lasting 12-24 hrs;
Malaise; This case was reported by a physician via call center representative and described the occurrence of malaise in a female patient who received Men B NVS (Bexsero) for prophylaxis.   On an unknown date, the patient received Bexsero at an unknown dose. On an unknown date, unknown after receiving Bexsero, the patient experienced malaise. On an unknown date, the outcome of the malaise was recovered/resolved.   It was unknown if the reporter considered the malaise to be related to Bexsero.  Additional details were provided as follows: The age at vaccination was not reported. The physician reported that, the patient received dose of Bexsero and experienced malaise for 4 days. The reporter consented to follow up.
Systemic: Confusion-Mild, Additional Details: Pt reported that she is not sure she received the vaccine, as she felt a splatter on her face/arm when the vaccine was administered.  Pt does not report any adverse side effects.
She received the Shingrix vaccination in her right arm on 12/7/22. Her arm became very warm, itchy, and very swollen on 12/12/2022. The pharmacist advised the patient to contact her primary care physician about these symptoms. Patient reported to me on 12/23/22 that her symptoms lasted for 3 days and her symptoms had now resolved.
Got wicked anxiety; Felt kind of sick; Freaked him out enough not to get the 2nd one; Tested positive for Covid Jun or Jul 13 2021; More than 35 days and hasn't received 2nd shot; Really tired; This spontaneous case was reported by a consumer and describes the occurrence of ANXIETY (Got wicked anxiety), MALAISE (Felt kind of sick), VACCINATION COMPLICATION (Freaked him out enough not to get the 2nd one), COVID-19 (Tested positive for Covid Jun or Jul 13 2021) and PRODUCT DOSE OMISSION ISSUE (More than 35 days and hasn't received 2nd shot) in a 25-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 21-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ANXIETY (Got wicked anxiety), MALAISE (Felt kind of sick), VACCINATION COMPLICATION (Freaked him out enough not to get the 2nd one), COVID-19 (Tested positive for Covid Jun or Jul 13 2021), PRODUCT DOSE OMISSION ISSUE (More than 35 days and hasn't received 2nd shot) and FATIGUE (Really tired). At the time of the report, ANXIETY (Got wicked anxiety), MALAISE (Felt kind of sick), VACCINATION COMPLICATION (Freaked him out enough not to get the 2nd one), COVID-19 (Tested positive for Covid Jun or Jul 13 2021) and FATIGUE (Really tired) outcome was unknown and PRODUCT DOSE OMISSION ISSUE (More than 35 days and hasn't received 2nd shot) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: positive (Positive) Tested positive for Covid.     mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was temporarily withheld on an unknown date.       No concomitant product information was provided.  Treatment information was not provided.  Patient tested positive for COVID-19 on 13-JUN-2021 or 13-JUL-2021 and not remember the exact date.
Day 1 - evening of vaccination - injection area was red and sore. Day 2 - injection site still sore and area of redness was spreading. Day 3 - redness still spreading, itchiness, and development of wheezing and felt like a "lump" or "egg" in her throat.
Tinnitus right ear.  Started exactly 24 hours after vaccination and is still going on two and a half hours later.
I RECIEVED THE VACCINE ON 12/29 @ 0900. THAT AFTERNOON I DEVELOPED A HEADACHE AND EXTREME FATIGUE. THE NEXT DAY 12/30 I DEVELOPED REDNESS AT INJECTION SITE AND STARTED TO BECOME HOT AND ITCHY. IT IS NOW 01/08/2021 AND I AM STILL BATTLING HEADACHE AND INJECTION SITE SORENESS.
Pt noted to be lifeless on awaking in morning.  Epistaxis reported by father.
Mom reported @ clinic appt on 24APR91 pt had high fever & rash starting 4-5 days p/vax; Temp not taken; Pt seen by MD 1APR; dx URI & bronchitis rx'd Rondec, Amoxicillin, APAP;
dose was given after expiration date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (dose was given after expiration date) in a 20-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Oct-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (dose was given after expiration date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (dose was given after expiration date) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication information provided.  It was reported that there was a confusion between the expiration date printed in the carton and the expiration date when the QR code was scanned.  The vial did not undergo any temperature excursion.  Date of vaccine placed in refrigerator was 05-Nov-2021.  Patient did not experience any adverse event.  No treatment information provided
Information has been received from a licensed practical nurse (L.P.N.) concerning a 14 month old male on 05-JUN-2008 was vaccinated subcutaneously in the right leg with a 0.5 ml dose of VARIVAX (Merck) (lot # 657106/1891U).  He was vaccinated concomitantly in his left leg with a dose of PREVNAR and a dose of MMRII.  On 05-JUN-2008 immediately post vaccination the patient experienced hives around the injection site of right leg.  The patient was treated with BENADRYL and monitored.  Subsequently, the patient recovered from hives around the injection site of right leg.  No product quality complaint was involved.  Additional information has been requested.
8/18/2021  Admit hospital with COVID Breakthrough .Generalized weakness, cough and chest congestion for the last few days.  His wife is also positive. Diagnosed with: minor COVID-19 symptoms, COVID-19 pneumonia Note: patient previously vaccinated with Pfizer COVID-19 vaccine, 2nd dose on 2/10/21. 8/19/21: Discharged
Fever 102F, chills, nausea, pain with edema and redness in left deltoid at injection site area, severe headache.
Slightly thump in throat; Trouble swallowing; Slightly swollen glands in throat; This is a spontaneous report from a contactable consumer, the patient. This is the first of two reports. A 36-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: unknown) via an unspecified route of administration in the arm left on 09Apr2021 at 16:30 (at the age of 36-year-old) as dose 1, single for COVID-19 immunisation. Medical history included anxiety from 2021, hemorrhage after giving birth in 2018, blood transfusion in the year 2018 and DNC (uterine dilation and curettage) to address it. Concomitant medications included Prenatal vitamins (MANUFACTURER UNKNOWN), ascorbic acid (VITAMIN C) but day b4, vitamin d NOS (VITAMIN D) for an unknown indication received within two weeks of vaccination. The patient was not diagnosed with COVID-19 prior to vaccination. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not have any known allergies, the patient reported that she never had any reaction to vaccines. On 09Apr2021 after 30 minutes of first dose vaccination, the patient experienced trouble swallowing, slightly swollen glands in throat. The patient reported as able to swallow with water. Called nurse and was not concerned because could breathe. The patient did not have rash and no other symptoms. Slept and next day, the patient experienced slightly thump in throat but subsided. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of trouble swallowing and slightly swollen glands in throat were unknown. The clinical outcome of slightly thump in throat was recovered on an unknown date in 2021.   No follow-up attempts are needed, information about lot/batch number cannot be obtained.
One week after the vaccine I was find until....I got out of my car after driving and started staggering and could not function.  Severe dizziness, heavy headedness , nausea and vomiting and a horrible headache.  My husband had to physically muscle me back to my car. He wanted to take me to the ER and I would not let him because of the waiting room is full of COVID positive patients.  I threw up along the way home and multiple times to the point I had drive heaves.  I am a Registered Nurse and felt the symptoms I were experiencing were Vertigo.  I had one bout with Vertigo in 2015 and it was extreme.  I had Meclizine on hand and and took one tablet and slept.  The severity of this was so bad I could not walk unassisted or sit up without falling over. After 6 hours of sleeping I got up, dizziness continued, and vision a little off.  I still do not feel 100% I have had a headache since.  It never dawned on me this could be from the vaccine I had taken a week before.
This spontaneous report as received from a registered nurse refers to a patient of unknown demographics. The patient's concurrent conditions, medical history, drug reactions/allergies and concomitant therapy were not reported. On 23-JUL-2018, the patient was vaccinated with improperly stored doses of Oka-Merck PROQUAD either from lot # R002939, expiry date: 29-JUL-2019 or lot # R006218, expiry date: 28-AUG-2019 (dose, frequency and route were not reported) for prophylaxis. DILUENT MRK INJ was properly stored. No adverse effects were reported. No product quality complaint was involved. The Oka-Merck PROQUAD was stored in temperature of 15 degree Fahrenheit (F) to 46 F for 14 hours on 16-JUN-2018. No previous temperature excursion was reported. A digital data logger was involved. This is one of several reports received from the same reporter. Sender's Comments: US-009507513-1808USA001261: US-009507513-1808USA004381:Original Case : 1808USA001261 US-009507513-1808USA004382:Original Case : 1808USA001261 US-009507513-1808USA004383:Original Case : 1808USA001261 US-009507513-1808USA004384:Original Case : 1808USA001261 US-009507513-1808USA004385:Original Case : 1808USA001261 US-009507513-1808USA004380:Original Case : 1808USA001261 US-009507513-1808USA004379:Original Case : 1808USA001261 US-009507513-1808USA004376:Original Case : 1808USA001261 US-009507513-1808USA004377:Original Case : 1808USA001261 US-009507513-1808USA004378:Original Case : 1808USA001261 US-009507513-1808USA004386:Original Case : 1808USA001261 US-009507513-1808USA004387:Original Case : 1808USA001261 US-009507513-1808USA004388:Original Case : 1808USA001261 US-009507513-1808USA004362:Original Case : 1808USA001261 US-009507513-1808USA004363:Original Case : 1808USA001261 US-009507513-1808USA004364:Original Case : 1808USA001261 US-009507513-1808USA004389:Original Case : 1808USA001261 US-009507513-1808USA004391:Original Case : 1808USA001261 US-009507513-1808USA004392:Original Case : 1808USA001261 US-009507513-1808USA004393:Original Case : 1808USA001261 US-009507513-1808USA004394:Original Case : 1808USA001261 US-009507513-1808USA004395:Original Case : 1808USA001261 US-009507513-1808USA004396:Original Case : 1808USA001261 US-009507513-1808USA004365:Original Case : 1808USA001261 US-009507513-1808USA004366:Original Case : 1808USA001261 US-009507513-1808USA004367:Original Case : 1808USA001261 US-009507513-1808USA004397:Original Case : 1808USA001261 US-009507513-1808USA004398:Original Case : 1808USA001261 US-009507513-1808USA004399:Original Case : 1808USA001261 US-009507513-1808USA004368:Original Case : 1808USA001261 US-009507513-1808USA004369:Original Case : 1808USA001261 US-009507513-1808USA004400:Original Case : 1808USA001261 US-009507513-1808USA004401:Original Case : 1808USA001261 US-009507513-1808USA004370:Original Case : 1808USA00126
got the vaccine and it gave me shingles/suspected vaccination failure; shingles; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure was unknown and the outcome of the shingles was not recovered/not resolved.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.     Additional Information: GSK receipt date: 12-June-2022 Reporter's comment: This case was reported by a consumer via interactive digital media. The patient got the vaccine and experienced shingles. The patient have to take medicine every single day just to keep from having a flare up. Additional Supportive Information: This case was considered as suspected vaccination failure since the details regarding completion of primary vaccination schedule, time to onset and laboratory confirmation of shingles not provided.
Muscle aches, headache, intense fatigue (like the worst of my life - where all I could do was lie around) and a pressure in my chest.
Painful sore arm, redness, swelling. The swelling and redness when down but tendinitis developed and is still present six months later. Interfere with daily life. Hard to do simple tasks such as fix hair, cook, and care for my family.
pt recv vax & 10min went by mom of child noticed red splotches all over child face;taken to MD who gave APAP & DPH;
9 x 5 cm red warm area on (R) upper arm. Nausea, vomiting, low grade fever, pulse 96. Itching to (R) arm, diarrhea.
01/27/2021, Woke with arm pain, lasted a day. On Feb 4th, I woke with my hands very itchy, I had a blistery rash on palms and going to back of hands and up wrist, it spread to my back. By that night my mouth had blisters inside and blisters showed up on my feet, I contacted my Dr. I waited 3 days later and contacted Dr. again, did telehealth visit. I saw dermatologist in Feb (date unknown). Was diagnosed with Lachine Planus.
Pt received Pnu-Imune IM in left deltoid on 4/5/01 at 09:15 and by 14:00 that day, she developed arm pain, golf ball sized swelling. The following day, she saw physician. She received Epinephrine and another (?) medication IM.
Pain near injection site getting increasingly worse.  By 9 days after, couldn't move my upper arm away from my body without intense pain.  Went to urgent care because my doctor didn't have appointment.  Now 2 weeks after, still cannot move arm away from body.  Pain a bit decreased at this time
vaccine administered on 3/9/21. Newly diagnosed shingles on 4/13/21.
The following morning after receiving the vaccine you work around 6AM my arm was really sore and my husband had to help me get dressed for work. I went to work and let my supervisor know my arm really sore. I left the office to go do my regular patrolling and started noticing that I had a really bad headache,  and I went and got something to eat. I ate some cereal and I got nauseated and I kept getting some chills. I went back to the office to do some paperwork and when I tried to walk it hurt. I told my coworker told me to get get something warm on my stomach, I tried to it but it made it nauseated. I ended up leaving work early and going home laid down  and have felt bad since. I can't not laid flat down as it uncomfortable, I propped myself up the bed. I have been up since 4am and have not been able to sleep since. I called the place where I received the vaccine at and they referred me to file a VAERS report. Had COVID in November 2020.
Vaccine given on 11/13/19. Arm swelling, redness, warm to touch, itchy, burning starting a week after vaccination, lasting a few weeks, prompting medical examination on 12/2/19.
Pain both shoulders, and neck,  TM joint pain on left,  acute tendonitis right shoulder, inflamed node at base of right neck,  trunkall erythema, facitis left foot.  Symptoms started two days after vaccine and now gradually improving in severity (10/18/2022).
I had a fever, chills, headache, and fatigue. A week later, I'm still not feeling 100%. The scariest reaction was a rash that broke out all over my chest. I also had one on my forehead. It looked like lacerations and I still have marks left behind. The rash on my chest was very hot and I had trouble breathing at night. I took pictures.
Systemic: Tremors on both hands and legs-Medium, Systemic: Shakiness-Medium
fever; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included Aderall, Anti-Thyroid medication, Progestrone, FEXOFENADINE HYDROCHLORIDE (ALLEGRA) and DULOXETINE for an unknown indication.    On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Apr-2021, the patient experienced PYREXIA (fever). At the time of the report, PYREXIA (fever) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
feelingtired; have low fever; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (feelingtired) and PYREXIA (have low fever) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced FATIGUE (feelingtired) and PYREXIA (have low fever). At the time of the report, FATIGUE (feelingtired) and PYREXIA (have low fever) outcome was unknown.            Action taken with mRNA-1273 in response to the event was not applicable. No concomitant medications were reported. Treatment information was unknown.
patient woke up saturday morning with rash on left arm , leg and puffy face.   mother gave benadryl for  the allergic reaction.  i suggested if symptoms get worse or difficulty in breathing or swallowing to go  to emergency department for further treatment
Drug eruption rash over breasts; This is a spontaneous case received from a contactable physician. A 27-year-old non-pregnant female patient received bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/Lot Number was not reported) via an unspecified route of administration on 13Aug2021 (age at vaccination 27-year-old) as DOSE NUMBER UNKNOWN, SINGLE for COVID-19 immunization. The patient was not pregnant at time of vaccination. The patient medical history and concomitant medication was reported as none. Prior to vaccination, the patient was not diagnosed with COVID-19. On 15Aug2021, the patient experienced drug eruption rash over breasts. Since the vaccination, the patient had not been tested for COVID-19. Event resulted to visit doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Seriousness of the event was reported as non-serious. Therapeutic measures were taken as a result of the events with topical steroids and antihistamine. The outcome of the event was not recovered.  Follow-up attempts are completed. No further information is expected